Erenumab monoclonal antibody drug. Targets calcitonin gene-related peptide receptor (CGRPR); used in treatment of migraine. #186823616
Description
Erenumab monoclonal antibody drug. Targets calcitonin gene-related peptide receptor (CGRPR); used in treatment of migraine. Generic name and stylized antibody representation